# Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the Esophagus

> **NCT00002631** · PHASE3 · COMPLETED · sponsor: **Radiation Therapy Oncology Group** · enrollment: 298 (estimated)

## Conditions studied

- Esophageal Cancer

## Interventions

- **DRUG:** chemotherapy
- **DRUG:** cisplatin
- **DRUG:** fluorouracil
- **RADIATION:** low-LET electron therapy
- **RADIATION:** low-LET photon therapy

## Key facts

- **NCT ID:** NCT00002631
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-06
- **Primary completion:** 1999-09
- **Final completion:** —
- **Target enrollment:** 298 (ESTIMATED)
- **Last updated:** 2013-11-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002631

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002631, "Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Cancer of the Esophagus". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00002631. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*